NasdaqGM - Nasdaq Real Time Price USD
Ikena Oncology, Inc. (IKNA)
1.1300
+0.0500
+(4.63%)
At close: May 9 at 4:00:01 PM EDT
1.1300
0.00
(0.00%)
After hours: May 9 at 4:05:12 PM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.12 | -0.11 | -0.51 | 0 |
| Low Estimate | -0.12 | -0.11 | -0.51 | 0 |
| High Estimate | -0.12 | -0.11 | -0.51 | 0 |
| Year Ago EPS | -0.27 | -0.2 | -0.93 | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 2 | 2 | 2 | 2 |
| Avg. Estimate | -- | -- | -- | -- |
| Low Estimate | -- | -- | -- | -- |
| High Estimate | -- | -- | -- | -- |
| Year Ago Sales | -- | -- | -- | -- |
| Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.3 | -0.29 | -0.17 | -0.16 |
| EPS Actual | -0.27 | -0.2 | -0.18 | -0.15 |
| Difference | 0.03 | 0.1 | -0.01 | 0.01 |
| Surprise % | 9.87% | 33.83% | -7.06% | 6.94% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.12 | -0.11 | -0.51 | 0 |
| 7 Days Ago | -0.14 | -0.12 | -0.53 | 0 |
| 30 Days Ago | -0.14 | -0.12 | -0.53 | 0 |
| 60 Days Ago | -0.14 | -0.12 | -0.53 | 0 |
| 90 Days Ago | 0 | 0 | -0.84 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | 1 | -- |
| Up Last 30 Days | -- | 1 | 1 | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| IKNA | 55.62% | 43.65% | 45.08% | -- |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | HC Wainwright & Co.: Buy to Buy | 11/11/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 8/12/2024 |
| Downgrade | Wedbush: Outperform to Neutral | 5/29/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 5/29/2024 |
| Reiterates | Wedbush: Outperform to Outperform | 5/14/2024 |
| Reiterates | HC Wainwright & Co.: Buy to Buy | 3/19/2024 |
Related Tickers
EPIX ESSA Pharma Inc.
1.7200
+0.58%
ANTX AN2 Therapeutics, Inc.
1.2000
-1.64%
HLVX HilleVax, Inc.
1.9000
-0.52%
LVTX LAVA Therapeutics N.V.
1.2500
-1.57%
PMVP PMV Pharmaceuticals, Inc.
0.8827
-0.12%
TBPH Theravance Biopharma, Inc.
8.98
-9.29%
GLTO Galecto, Inc.
2.7450
-1.96%
BOLT Bolt Biotherapeutics, Inc.
0.3580
-3.24%
KZR Kezar Life Sciences, Inc.
4.2200
+2.43%
SPRO Spero Therapeutics, Inc.
0.6200
+7.83%